05Sep
04Sep
Board adds $1M to help get more Utah students connected to internet
The board also approved setting aside $452,000 from the Utah K-12 CARES set aside funds to obtain a K-12 license for Scrible. Scrible is a tech-based writing, research, annotation and collaboration platform to support digital learning and teaching. Read more >>
04Sep
Managing Your Student Loan Payments During COVID-19
The COVID-19 pandemic has affected nearly every aspect of life on a global scale. As we are forced to observe varying degrees of shelter-in-place and phased reopenings, millions of Americans are out of work and searching for their next paycheck. If you find yourself in this situation and you have student loan debt, you might be worried about making payments. On the other hand, you may be fortunate enough to make your payments but aren’t sure where to start. Read...
03Sep
Myomo® Receives First Australian Insurance Authorization for MyoPro™
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that a Myomotrained Orthotic & Prosthetic (“O&P”) practice in Australia has received its first insurance authorization to fit a patient with a custom MyoPro device. Read more >>
02Sep
Jay Blankenship M.D. Joins Zylö as Vice President of Business Development
Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced Jay Blankenship M.D. has joined its executive team as vice president of business development. Read more >>
02Sep
TRACER to support Akston Biosciences’ Phase 1 clinical study of AKS-452, an innovative anti-COVID-19 vaccine
BEVERLY, Mass., USA & GRONINGEN, the Netherlands, Sept. 01, 2020 Today, TRACER Europe B.V., a Clinical Research Organization (CRO) specializing in fast-track solutions for testing innovative biologic medicines, announced that it will support Akston Biosciences Inc., a leader in the development of novel Fc fusion protein therapeutics, in the Phase 1 clinical testing in the Netherlands of Akston’s lead COVID-19 vaccine candidate, AKS-452. Read more >>
28Aug
KnipBio says its SCP meal has benefits for RAS production
KnipBio reports that fish fed a diet containing 5% of its KnipBio Meal (KBM) – a single cell protein - had signicantly lower levels of geosmin and methylisoborneol (MIB), the compounds responsible for creating off-flavors in RAS-raised fish. Read more >>
27Aug
XYLYX BIO releases highly physiologic 2D substrates for improved antifibrotic drug discovery
New York-based Xylyx Bio, a leader in advanced disease models, today announced the release of normal and fibrotic NativeCoat™ human lung- and liver-specific ECM substrates for antifibrotic drug discovery to increase predictiveness of high throughput screening and improve evaluation of efficacy of biopharmaceutical drug candidates for hard to treat fibrotic diseases such as IPF and NASH. Read more >>
27Aug
Myomo® Extends and Strengthens its Global MyoPro™ Patent Portfolio
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced additional intellectual property protection with the issuance of new patents in the U.S. and Europe related to MyoPro™, its unique wearable robotic brace for arm and hand paralysis. Read more >>
26Aug